References in periodicals archive ?
About the OncAlert Oral Cancer Risk Assessment System Vigilant's initial product, the OncAlert Oral Cancer Risk Assessment System, includes the OncAlert Oral Cancer Rapid Point-of-Care Risk Assessment Test and the OncAlert Oral Cancer CD44 + Total Protein Lab Test.
The poster presentation, entitled, "6 peptide binds to CD44 and inhibits migration and metastasis of CD44+ cell lines in in vitro and in vivo studies," covers pre-clinical work completed by Bio-Quant on ngstrom's lead product, 6, currently in Phase 2 development for ovarian cancer.
Antigen CD29 CD44 CD90 CD105 CDI66 CD31 CD16 Content (%) 98.
Uromodulin, SERPINF1 (serpin peptidase inhibitor, clade F, [alpha]-2 antiplasmin, pigment epithelium derived factor, member 1), and CD44 were verified in an independent cohort and shown to differentiate patients with AR from other groups.
Poster #4293: Evaluation of activated CD44 as a biological target in the eradication of breast cancer stem cells
They also exhibited increased transcription and expression of OCT4, CD44, and CXCR4.
Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.
Our preliminary data strongly suggests that vitamin D suppression of HAS2 activity and HA synthesis represents a feasible approach for interrupting the CD44 signaling process in TNBC cells.
The expression of CSC markers such as CD44, CD24, and ALDH1 has also been shown in CTCs by both molecular assays (42) and imaging (73).
The major genes that have been shown to be epigenetically altered in prostate cancers include cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), cadherin 1, type 1, E-cadherin (epithelial) (CDH1), CD44 molecule (Indian blood group) (CD44), O-6-methylguanine-DNAmethyltransferase (MGMT), Ras association (RalGDS/AF-6) domain family member 1 (RASSF1A), ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1), adenomatous polyposis coli (APC), and glutathione S-transferase pi 1 (GSTP1).
The wide array of molecular-based PCa markers includes proliferation index (Ki-67), microvessel density, nuclear morphometry, tumor suppressor genes (eg, TP53, CDKN1A, CDKN1B, NKX3-1, PTEN, and the retinoblastoma gene Rb), oncogenes (eg, BCL2, MYC, EZH2, and ERBB2 [formerly HER2/neu]), adhesion molecules (eg, CD44 and E-cadherin), the PI3K/Akt/mTOR (mammalian target of rapamycin) pathway, (30,31) apoptosis regulators (eg, survivin and transforming growth factor p1), androgen receptor status, neuroendocrine differentiation markers, and prostate tissue lineage-specific markers (PSA, prostate-specific acid phosphatase, and prostate-specific membrane antigen).
EPR subjects with functional SNPs in CD44 (receptor for hyaluronic acid) and I [alpha]I (inter-[alpha]-inhibitor) will be exposed to ozone via inhalation and examined for bronchoconstrictive responses to inhaled methacholine.
Acronyms browser ?
Full browser ?
- CD4/CD8 ratio
- CD4:CD8 count
- CD40 antigen ligand
- CD40 associated protein 1
- CD40 binding protein
- Cd40 ligand
- CD40 Receptor Associated Factor 1
- CD40 Receptor Associated Factor 1
- CD40 receptor-associated factor 1
- CD40-binding protein
- CD42a antigen
- CD42b antigen
- CD42c antigen
- CD42d antigen
- CD44 antigen
- CD44 molecule
- CD45 antigen
- CD49 antigen-like family member A
- CD49 antigen-like family member B
- CD49 antigen-like family member C
- CD49 antigen-like family member D
- CD49 antigen-like family member E
- CD49 antigen-like family member F
- CD49a antigen
- CD49b antigen
- CD49c antigen
- CD49d antigen
- CD49e antigen
- CD49f antigen
- CD4CD8 count
- CD5 antigen